Albert Bondt

Albert Bondt is a Research Fellow and Project Manager in the Biomolecular Mass Spectrometry and Proteomics group at Utrecht University's Faculty of Science. He leads research on antibody proteomics, focusing on immunoglobulin characterization using advanced mass spectrometry techniques. Previously affiliated with Erasmus MC and Leiden University Medical Center, his work bridges rheumatology, virology, and lactation science.

Research Focus: Bondt's work centers on:

• Antibody glycosylation and proteoform analysis
• High-resolution profiling of immunoglobulin repertoires (IgG1/IgA1)
• Method development for clinical proteomics applications
• Immune response dynamics in autoimmune diseases and infections

His research employs cutting-edge LC-MS/MS and native top-down mass spectrometry to study antibody structures in biofluids.

Publication Trends: His 15 most recent articles (2021-2025) demonstrate:

• Pioneering work in antibody repertoire personalization across diseases (RA, COVID-19)
• Innovative techniques for clonal profiling of immunoglobulins
• Translational applications in diagnostics and vaccine response monitoring
• Cross-disciplinary collaborations in rheumatology, virology, and nephrology